Calton & Associates’s Crocs CROX Stock Holding History

Calton & Associates’s Portfolio CROX Stock Details CROX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,712	Closed	-$283K	–	262
2022 Q1	$283K	Buy	+3,712	New	+$351K	0.08%	263

Other funds holding CROX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BPIH

Broad Peak Investment Holdings Singapore $531M AUM 24.06% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Calton & Associates's CROX Position: Q2 2022 in Review

Calton & Associates sold out of Crocs (CROX) in Q2 2022, closing a stake of 3,712 shares — an estimated $283K sold.

Calton & Associates first reported a position in CROX in Q1 2022 and held it in 1 quarter. The position peaked at $283K in Q1 2022. 360 funds tracked by Wall St. Rank hold CROX as of Q2 2022.

Calton & Associates reported no remaining Crocs position as of Q2 2022 after selling out during the quarter.
Calton & Associates sold 3,712 Crocs shares in Q2 2022, an estimated $283K.
Calton & Associates first reported a position in Crocs in Q1 2022 and held it in 1 quarter.
Calton & Associates's Crocs position peaked at $283K in Q1 2022.
360 funds tracked by Wall St. Rank held Crocs as of Q2 2022.

Based on Calton & Associates's 13F filing for Q2 2022, filed 12 Jul 2022.